abstract |
The present invention discloses the use of 5α-androst-3β,5,6β-triol and its analogues, deuterium or pharmaceutically acceptable salts thereof in the preparation of a drug for the treatment of hemorrhagic stroke in a patient. The hemorrhagic stroke is the simultaneous occurrence of parenchymal hemorrhage, subarachnoid hemorrhage, or both. |